Why is Natco Pharma falling/rising?

As of 03-Jul, Natco Pharma Ltd. is experiencing a rise in its stock price, currently at 973.55, reflecting an increase of 48.55 or 5.25%. The stock has shown strong performance today, outperforming its sector by 4.77% and reaching an intraday high of Rs 976.75. Over the past week, Natco Pharma has gained 11.68%, while its one-month return stands at 13.02%. Despite a year-to-date decline of 29.81%, the company has demonstrated healthy long-term growth, with an operating profit growth rate of 32.35% and a return on equity (ROE) of 24.8, indicating a very attractive valuation. Additionally, the stock is trading at a discount compared to its peers, and high institutional holdings at 23.15% suggest confidence from more knowledgeable investors. However, it is worth noting that there has been a decline in investor participation, with delivery volume falling by 6.85% against the five-day average.
In the broader market context, Natco Pharma's recent performance contrasts sharply with the Sensex, which has seen a slight decline of 0.62% over the past week. This indicates that while the stock is rising, the overall market sentiment may not be as favorable. The company's ability to outperform the sector and its positive financial metrics, such as a low debt-to-equity ratio and a PEG ratio of 0.3, contribute to its resilience in a challenging market environment. Despite the broader market trends, Natco Pharma's strong fundamentals and recent price movements suggest a positive outlook for the stock.